Measure | Smekal et al.43 | Ferran et al.44 | Witzel et al.45 | Judd et al.18 | Chen et al.17 | Chen et al.46 |
---|---|---|---|---|---|---|
Allocation concealment | 2 | 2 | 2 | 2 | 0 | 0 |
Intention-to-treat analysis | 2 | 2 | 0 | 0 | 0 | 0 |
Assessor blinding | 0 | 0 | 0 | 0 | 0 | 0 |
Comparable baseline characteristics | 2 | 2 | 2 | 2 | 2 | 2 |
Participant blinding | 0 | 0 | 0 | 0 | 0 | 0 |
Treatment–provider blinding | 0 | 0 | 0 | 0 | 0 | 0 |
Care program comparability | 2 | 2 | 2 | 2 | 0 | 1 |
Defined inclusion and exclusion criteria | 2 | 2 | 2 | 2 | 2 | 2 |
Well-defined interventions | 2 | 2 | 2 | 2 | 2 | 0 |
Well-defined outcome measure | 2 | 2 | 2 | 2 | 2 | 2 |
Clinically useful diagnostic tests | 2 | 2 | 2 | 2 | 2 | 2 |
Adequate duration of follow-up | 2 | 2 | 2 | 2 | 2 | 2 |
Score | 18 | 18 | 16 | 16 | 12 | 11 |